At Kenvue, our goal is always to put the power of everyday care into the hands of consumers around the world. We boldly pursue more innovative ways of working and pioneer solutions that improve lives — and 2024 was no exception.
From allergy medicine that melts in your mouth to the European launch of one of our favorite Kenvue brands, here are a few of the moments that made our year.
Product launch: Tylenol® Easy to Swallow Caplets
Are you one of the 40% of adults who have difficulty swallowing pills? Avoiding certain medications can prevent you from getting the relief that you need, but one of the latest innovations from the Tylenol® team hopes to change that.
Each of the caplets features a Gentleglide™ coating, which is a specialized technology that helps those who struggle with taking pills, caplets or tablets. This addition to the Tylenol® line provides the fast-acting, strong pain relief you need in a form that is easy to swallow.
We published the largest integrated clinical analysis on retinol for anti-aging
For years, retinol has been the bedrock of skin care products proven to effectively reduce visible signs of aging across our iconic brands such as science-backed Neutrogena® and Dr.Ci:Labo®. But to support further skin care innovation, in April we released a new integrated clinical analysis on efficacy and tolerability data published in the Journal of Drugs in Dermatology supporting 0.1% retinol as the cosmetic solution to target signs of skin aging. The clinical assessment was the largest to be published in scientific literature on the ingredient and found that retinol induced greater improvements from baseline as compared to placebo in the signs of photoaging evaluated, as early as week four.
We launched Aveeno® in Central Europe
For generations, our consumers have used Aveeno® to provide beneficial and nourishing skincare for sensitive skin. But still, millions of people around the world suffer from skin conditions like eczema, or simply cannot find the right product for their skin type. This is why we have been on a mission to meet the growing demand for expert-backed solutions and in September 2024, officially launched Aveeno® in 12 Central European markets. Aveeno® will be available exclusively in pharmacies, where customers can consult healthcare professionals to address their sensitive skin needs.
Product launch: Zyrtec® Dissolve Tabs
It’s never pleasant when allergy symptoms like sneezing, runny nose and itchy eyes hit, but it’s even harder to deal with when you’re on the go and taking medication just isn’t convenient.
Whether your symptoms are caused by indoor allergens like dust, pet dander or mold, or by outdoor allergens like grass and tree pollen, Zyrtec® Dissolve Tabs can provide allergy relief. Zyrtec® Dissolve Tabs treat symptoms that may triggered by more than 200 different allergens, ensuring you are covered. These tablets start working at hour one, provide relief for a full 24 hours, and dissolve instantly without the need for water — making them perfect for moments when you’re on the go.
We launched the Smokefree Families campaign in the UK
With an estimated 1.8 million households in England with children having at least one smoker, in July 2024, we set out to work with general practitioner Dr. Zoe Williams to launch our Smokefree Families initiative in the UK. The campaign came after the new government announced plans to deliver a smokefree generation by reintroducing the Tobacco and Vapes Bill, which progressively increases the age at which people can buy cigarettes. As part of this initiative, we commissioned a survey of 2,000 current and previous smokers living with children in the UK – 1,800 of them parents – to examine attitudes to smoking and the motivators and barriers to quitting. Its major findings revealed that while 71% of smoking parents are keen to quit, many feel unsupported. Also, 75% of parents identify saving money as an important reason to give up smoking, and although parents recognize the importance of taking care of their own everyday health, 64% cited improving children’s health as motivation to quit. As part of the campaign, we developed a series of tools and materials to support healthcare professionals with their conversations with new and expectant parents, their partners and support networks, and smokers with young children, on their quit journey.
Product launch: Neutrogena® Collagen Bank™
A naturally occurring protein in the body, collagen is the primary supporting structure in your skin, hair, bones, muscles, and connective tissues. Did you know, starting in your 20s, you lose up to 1% of skin’s collagen each year? This can result in lines, wrinkles and a loss of elasticity.
The new Neutrogena® Collagen Bank™ skincare line is formulated to strengthen the collagen you have and build the collagen you don’t. For example, the Daily Face Moisturizer With SPF 30 — enhanced with patented micro-peptide technology that penetrates more than 10 surface layers deep — instantly leaves skin feeling plumper, is lightweight and won’t leave a white cast.
Product launch: Aveeno® Daily Moisturizing Cream
When you think of oatmeal, you might think of a popular breakfast option, but the prebiotic oat that we use in this innovative Aveeno® product instantly strengthens skin’s moisture barrier and keeps skin hydrated for 48 hours. Designed for normal to dry, sensitive skin, the velvety body and face cream is formulated with an indulgent combination of prebiotic oat and shea butter that’s clinically proven to leave skin soft, soothed and nourished. It’s also free of fragrances, dyes, parabens and phthalates, and is non-comedogenic, so it won’t clog your pores.
We launched a new brand focused on menopause — Versalie™
Knowing menopause is not a one-size-fits-all experience, Kenvue spent more than three years creating Versalie™ — a first-of-its-kind digital platform that provides individuals with evidence-based education on menopause, virtual access to menopause-trained healthcare professionals, and a curated storefront of products that is a one-stop-shop for menopause symptom relief — so each individual can confidently discover what might work best for them.
As dry and dull skin can be a symptom of menopause, Kenvue launched Versalie™ Skincare products, which have been clinically tested on menopausal complexions and are made to target the five visible signs of estrogen-depleted skin — loss of firmness and radiance, dryness, fine lines and wrinkles. Versalie™ Skincare products are also gentle, suitable for all skin tones and created with dermatologist-recommended active ingredients, including hyaluronic acid, pure collagen and retinol.